Abiopharma

Clinical trial NCT04219280 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2025-09-30 → 2026-08-31 3. primary completion date: 2025-09-30 → 2026-08-31

Clinical trial NCT07505810 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-03-22 → 2026-03-25

Clinical trial NCT07542886 updates: 1. status: NOT_YET_RECRUITING → COMPLETED 2. completion date: 2026-07-22 → 2026-07-24 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT02851992 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2028-09-01 → 2025-05-01 3. primary completion date: 2020-12-01 → 2020-05-01

Clinical trial NCT05382325 updates: 1. completion date: 2026-07-31 → 2026-09-30 2. primary completion date: 2026-07-31 → 2026-09-30

Clinical trial NCT05447585 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-12-10 → 2023-08-10 3. primary completion date: 2023-12-10 → 2023-08-10 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06401044 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-08-13 → 2027-12-24 3. primary completion date: 2027-02-22 → 2027-01-06 4. enrollment: 88 → 94 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07629960: start date: 2026-06-30 → 2026-06-04.

Clinical trial NCT07659782: start date: 2026-07-01 → 2026-07-22.

Clinical trial NCT07590531 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-06-29